- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02743130
Effects of Berry Nectars Sweetened With Inverted Sugar on Post-meal Blood Sugar
April 14, 2016 updated by: Riitta Törrönen, University of Eastern Finland
Postprandial Glycemic Response to Berry Nectars Containing Inverted Sugar
Berries have been shown to improve postprandial glucose and insulin responses to sucrose.
During processing and storage of berry products, sucrose is inverted to glucose and fructose.
The effects of berries on the glycemic response induced by inverted sugar are not known.
The purpose of this study is to determine whether berries are effective in lowering the postprandial glucose and insulin responses induced by inverted sugar.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kuopio, Finland, FI-70211
- University of Eastern Finland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 69 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 20-28 kg/m2
- Normal fasting plasma glucose
Exclusion Criteria:
- Smoking
- Diabetes or other chronic disease
- Antibiotic medication within the past 3 months
- Blood donation within the past month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Blackcurrant nectar
Contains 17.5 g glucose and 17.5 g fructose representing 35 g completely inverted sucrose
|
Consumption of a single dose (300 ml)
|
Experimental: Lingonberry nectar
Contains 17.5 g glucose and 17.5 g fructose representing 35 g completely inverted sucrose
|
Consumption of a single dose (300 ml)
|
Active Comparator: Reference
Sugar control, contains 17.5 g glucose and 17.5 g fructose in water
|
Consumption of a single dose (300 ml)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma glucose response
Time Frame: 2 hours
|
0, 15, 30, 45, 60, 90, 120 minutes post-meal
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma insulin response
Time Frame: 2 hours
|
0, 15, 30, 45, 60, 90, 120 minutes post-meal
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Riitta Törrönen, Dr, Senior Scientist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
April 14, 2016
First Submitted That Met QC Criteria
April 14, 2016
First Posted (Estimate)
April 19, 2016
Study Record Updates
Last Update Posted (Estimate)
April 19, 2016
Last Update Submitted That Met QC Criteria
April 14, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- INVE 903/020502/2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia, Postprandial
-
San Diego State UniversityRecruitingPostprandial Hyperglycemia | Postprandial Glycemic Response | Postprandial InsulinUnited States
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
San Diego State UniversityCompletedPostprandial Hyperglycemia | Postprandial InsulinUnited States
-
Clinica Universidad de Navarra, Universidad de...CompletedLipid Profile | Hyperglycemia, Postprandial | Feeding Behaviors | Antioxidant | PostprandialSpain
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Addis Ababa UniversityCompletedHyperglycemia, Postprandial
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
-
University of SharjahCompletedPostprandial HyperglycemiaUnited Arab Emirates
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
University of BergenCompleted
Clinical Trials on Blackcurrant Nectar
-
University of CopenhagenUniversity of Leeds; University of LiverpoolCompleted
-
Swallow SolutionsNational Institute of Nursing Research (NINR)UnknownDeglutition DisordersUnited States
-
Lucozade Ribena SuntoryKing's College LondonCompletedPostprandial PeriodUnited Kingdom
-
ISOThrive Inc.CompletedConstipationUnited States
-
Franklin Health ResearchArtemis InternationalCompleted
-
University of RochesterCompletedAcne Scars - Mixed Atrophic and HypertrophicUnited States
-
University of ChichesterCompletedno ConditionsUnited Kingdom
-
USDA Grand Forks Human Nutrition Research CenterCompleted
-
University of PrimorskaCompleted
-
University of ConnecticutCompletedCardiovascular Diseases | Gut Microbiota | Postmenopausal OsteoporosisUnited States